EDITORIAL
Published on 16 Jul 2024
Editorial: Liquid-biopsy-guided biomarker and drug discovery
doi 10.3389/fphar.2024.1454960
- 527 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Liquid-biopsy-guided biomarker and drug discovery
Liquid-biopsy-guided biomarker and drug discovery
3,570
Total downloads
11k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Published on 21 May 2024
Status of breast cancer detection in young women and potential of liquid biopsy
doi 10.3389/fonc.2024.1398196
- 1,364 views
- 1 citation
BRIEF RESEARCH REPORT
Published on 10 May 2024
Lysosomal degradation of PD-L1 is associated with immune-related adverse events during anti-PD-L1 immunotherapy in NSCLC patients
doi 10.3389/fphar.2024.1384733
- 1,356 views
- 3 citations
ORIGINAL RESEARCH
Published on 07 May 2024
Combination of plasma MMPs and PD-1-binding soluble PD-L1 predicts recurrence in gastric cancer and the efficacy of immune checkpoint inhibitors in non-small cell lung cancer
doi 10.3389/fphar.2024.1384731
- 1,516 views
- 2 citations
REVIEW
Published on 22 Apr 2024
Unveiling acquired resistance to anti-EGFR therapies in colorectal cancer: a long and winding road
doi 10.3389/fphar.2024.1398419
- 1,929 views
- 2 citations
ORIGINAL RESEARCH
Published on 13 Nov 2023
Natural killer cell-related prognosis signature predicts immune response in colon cancer patients
doi 10.3389/fphar.2023.1253169
- 1,546 views
- 4 citations
Published in
Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 11kTopic views
- 6,730Article views
- 3,570Article downloads